Europe Insomnia Market and Competitive Landscape – 2017

1. Insomnia: Disease Overview

1.1. Insomnia Symptoms

1.2. Insomnia Etiology

1.3. Insomnia Diagnosis

1.4. Insomnia Treatment Options

2. Insomnia Pipeline Insights

2.1. Insomnia Phase 3 Clinical Trials

2.2. Insomnia Phase 2 Clinical Trials

2.3. Insomnia Phase 1 Clinical Trials

3. Insomnia Epidemiology Analysis

4. Germany Insomnia Market Insights

4.1. Marketed Products for Insomnia in Germany

4.2. Germany Insomnia Market Size & Forecast

4.3. Germany Insomnia Product Sales Forecast

4.4. Germany Insomnia Market Share Analysis

5. France Insomnia Market Insights

5.1. Marketed Products for Insomnia in France

5.2. France Insomnia Market Size & Forecast

5.3. France Insomnia Product Sales Forecast

5.4. France Insomnia Market Share Analysis

6. Italy Insomnia Market Insights

6.1. Marketed Products for Insomnia in Italy

6.2. Italy Insomnia Market Size & Forecast

6.3. Italy Insomnia Product Sales Forecast

6.4. Italy Insomnia Market Share Analysis

7. Spain Insomnia Market Insights

7.1. Marketed Products for Insomnia in Spain

7.2. Spain Insomnia Market Size & Forecast

7.3. Spain Insomnia Product Sales Forecast

7.4. Spain Insomnia Market Share Analysis

8. UK Insomnia Market Insights

8.1. Marketed Products for Insomnia in UK

8.2. UK Insomnia Market Size & Forecast

8.3. UK Insomnia Product Sales Forecast

8.4. UK Insomnia Market Share Analysis

9. Europe Insomnia Market Insights

9.1. Europe Insomnia Market Size & Forecast

9.2. Europe Insomnia Product Sales Forecast

9.3. Europe Insomnia Market Share Analysis

10. Research Methodology

LIST OF TABLES

Table 1: Insomnia Phase 3 Clinical Trials, Global, 2017

Table 2: Insomnia Phase 2 Clinical Trials, Global, 2017

Table 3: Insomnia Phase 1 Clinical Trials, Global, 2017

Table 4: Insomnia Prevalence by EU5 Countries, 2012 - 2021

Table 5: Marketed Products for Insomnia in Germany, 2017

Table 6: Germany Insomnia Market Size & Forecast ($mn), 2012 - 2021

Table 7: Germany Insomnia Product Sales ($mn), 2012 - 2021

Table 8: Germany Insomnia Market Trends, 2012 - 2021

Table 9: Marketed Products for Insomnia in France, 2017

Table 10: France Insomnia Market Size & Forecast ($mn), 2012 - 2021

Table 11: France Insomnia Product Sales ($mn), 2012 - 2021

Table 12: France Insomnia Market Trends, 2012 - 2021

Table 13: Marketed Products for Insomnia in Italy, 2017

Table 14: Italy Insomnia Market Size & Forecast ($mn), 2012 - 2021

Table 15: Italy Insomnia Product Sales ($mn), 2012 - 2021

Table 16: Italy Insomnia Market Trends, 2012 - 2021

Table 17: Marketed Products for Insomnia in Spain, 2017

Table 18: Spain Insomnia Market Size & Forecast ($mn), 2012 - 2021

Table 19: Spain Insomnia Product Sales ($mn), 2012 - 2021

Table 20: Spain Insomnia Market Trends, 2012 - 2021

Table 21: Marketed Products for Insomnia in UK, 2017

Table 22: UK Insomnia Market Size & Forecast ($mn), 2012 - 2021

Table 23: UK Insomnia Product Sales ($mn), 2012 - 2021

Table 24: UK Insomnia Market Trends, 2012 - 2021

Table 25: Europe Insomnia Market Size & Forecast ($mn), 2012 - 2021

Table 26: Europe Insomnia Product Sales ($mn), 2012 - 2021

LIST OF FIGURES

Figure 1: Insomnia Pipeline by Phase (%), Global, 2017

Figure 2: Insomnia Prevalence by EU5 Countries, 2012 - 2021

Figure 3: Germany Insomnia Market Size ($mn), 2012 - 2021

Figure 4: Germany Insomnia Product Sales ($mn), 2012 - 2021

Figure 5: Germany Insomnia Market Share by Products (%), 2016

Figure 6: Germany Insomnia Market - Future Market Share (%), 2021

Figure 7: France Insomnia Market Size ($mn), 2012 - 2021

Figure 8: France Insomnia Product Sales ($mn), 2012 - 2021

Figure 9: France Insomnia Market Share by Products (%), 2016

Figure 10: France Insomnia Market - Future Market Share (%), 2021

Figure 11: Italy Insomnia Market Size ($mn), 2012 - 2021

Figure 12: Italy Insomnia Product Sales ($mn), 2012 - 2021

Figure 13: Italy Insomnia Market Share by Products (%), 2016

Figure 14: Italy Insomnia Market - Future Market Share (%), 2021

Figure 15: Spain Insomnia Market Size ($mn), 2012 - 2021

Figure 16: Spain Insomnia Product Sales ($mn), 2012 - 2021

Figure 17: Spain Insomnia Market Share by Products (%), 2016

Figure 18: Spain Insomnia Market - Future Market Share (%), 2021

Figure 19: UK Insomnia Market Size ($mn), 2012 - 2021

Figure 20: UK Insomnia Product Sales ($mn), 2012 - 2021

Figure 21: UK Insomnia Market Share by Products (%), 2016

Figure 22: UK Insomnia Market - Future Market Share (%), 2021

Figure 23: Europe Insomnia Market Size ($mn), 2012 - 2021

Figure 24: Europe Insomnia Product Sales ($mn), 2012 - 2021

Figure 25: Europe Insomnia Market Share by Products (%), 2016

Figure 26: Europe Insomnia Market - Future Market Share (%), 2021

Europe Insomnia Market and Competitive Landscape – 2017

The latest research from Fore Pharma, Europe Insomnia Market and Competitive Landscape – 2017, provides comprehensive insights into Insomnia pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Insomnia market size and drug sales. This research also provides insights into Insomnia epidemiology and late stage pipeline.
The report is classified into nine sections – Insomnia overview with definitions, symptoms, etiology, diagnosis, treatment options; Insomnia pipeline insights covering late stage clinical trials pipeline; Insomnia prevalence trends by countries; Insomnia market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes EU5 countries – Germany, France, Italy, Spain, UK, Europe.

Research Scope:

• Insomnia pipeline: Find out the drugs in clinical trials for Insomnia by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
• Insomnia epidemiology: Find out the prevalence of Insomnia by countries – Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2025
• Insomnia products: Identify key products marketed and prescribed for Insomnia by brand name, by molecule, by company, by branded / generic, by countries – Europe, Germany, France, Italy, Spain, UK, Japan
• Insomnia market size: Find out the market size for Insomnia drugs by countries – Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2012
• Insomnia drug sales: Find out the sales of Insomnia drugs by countries – Europe, Germany, France, Italy, Spain, UK
• Insomnia drugs sales forecast: Sales forecast for Insomnia drugs to 2021 by countries – Europe, Germany, France, Italy, Spain, UK, Japan
• Insomnia market share analysis: Find out the market shares of Insomnia drugs and outlook by countries – Europe, Germany, France, Italy, Spain, UK, Japan

Benefits of this Research: The research helps executives to

• Evaluate commercial market opportunities for Insomnia drugs
• Synthesize insights for business development & licensing
• Track market size, competitor drug sales, market shares in Insomnia market
• Develop in-depth knowledge of competition and markets
• Analyze sales data to update your brand planning trackers
• Develop tactics and strategies to take advantage of opportunities in the market
• Track market trends and analyze key events in Insomnia market
• Develop forecast models, healthcare frameworks, or economic models
• Answer key business questions; supports decision making in R&D to long term marketing strategies